Figure 18: Rituxan – SWOT 2010 48
Figure 19: Plavix, Global, Revenues ($m) 2007-2009 50
Figure 20: Plavix– SWOT 2010 51
Figure 21: Risperdal, Global, Revenues ($m) 2007-2009 53
Figure 22: Risperdal – SWOT 2010 54
Figure 23: Personalized Medicine Market, Biomarkers in Cancer Research, 2010 68
Figure 24: Personalized Medicine Market, Biomarkers in Cancer Research, Global, Cancer Biomarkers Market Revenues ($bn), 2007–2016 69
Figure 25: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Market Segmentation by Indication, 2009 70
Figure 26: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Breast Cancer Biomarkers Market Revenues ($m), 2007–2016 71
Figure 27: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Prostate Cancer Biomarkers Market Revenues ($m), 2007–2016 72
Figure 28: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Lung Cancer Biomarkers Market Revenues ($m), 2007–2016 73
Figure 29: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Colorectal Cancer Biomarkers Market Revenues ($m), 2007–2016 74
Figure 30: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Cervical Cancer Biomarkers Market Revenues ($m), 2007–2016 75
Figure 31: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Head and Neck Cancer Biomarkers Market Revenues ($m), 2007–2016 76
Figure 32: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Pancreatic Cancer Biomarkers Market Revenues ($m), 2007–2016 77
Figure 33: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Ovarian Cancer Biomarkers Market Revenues ($m), 2007–2016 78
Figure 34: Personalized Medicine Market, Global, Biomarkers in Cancer Research, Stomach Cancer Biomarkers Market Revenues (
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |